EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparison of the effectiveness of pirfenidone with corticosteroids in post-COVID fibrosis – A quasi experimental study

Muhammad Rafay Rasheed, Kulsoom Farhat, Shabana Ali, Ikramullah Khan, Rizwan Abdul Malik

Journal of the Pakistan Medical Association · 01.11.2026 · 76 (11) · 1824-1827

DOI: 10.47391/jpma.23212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Pakistan Medical Association, online erschienen am 01.11.2026. Verfasst von Muhammad Rafay Rasheed und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the effectiveness of corticosteroids with pirfenidone in patients of post-coronavirus disease-2019 pulmonary fibrosis in preventing long-term life-threatening sequelae.

Method

The quasi-experimental study was conducted at the Department of Pharmacology, Army Medical College, Rawalpindi, and the Department of Pulmonology, Pakistan Emirates Military Hospital, Rawalpindi, Pakistan, from January to December 2024, and comprised patients with post- coronavirus disease-2019 pulmonary fibrosis who were divided into Group-A receiving corticosteroids and Group-B receiving a combination of pirfenidone and corticosteroids. Pulmonary fibrosis was diagnosed on the basis of high-resolution computed tomography findings. The participants were subjected to 6-minute walk test and pulse-oximetry, while Warrick scores for pulmonary fibrosis were also noted for each participant at 3 and 6 months. Data was analysed using SPSS 26.

Results

Of the 40 patients, 20(50%) were in Group-A; 12(60%) males and 8 (40%) females with mean age 42.45±11.11 years. The other 20(50%) patients were in Group-B; 13(65%) males and 7(35%) females with mean age 43.15±8.64 years. Group-B showed higher improvement in 6-minute walk test compared to Group-A both at 90 days (p=0.189) and 180 days (p=0.002). Improvements in Oxygen saturation, Warrick score for fibrosis and fibrosis percentage were significantly higher in Group-B patients at 180-days follow-up as compared to Group-A (p

Zitieren

APA

Rasheed, M. R., Farhat, K., Ali, S., Khan, I., & Malik, R. A. (2026). Comparison of the effectiveness of pirfenidone with corticosteroids in post-COVID fibrosis – A quasi experimental study. Journal of the Pakistan Medical Association, 76(11), 1824-1827. https://doi.org/10.47391/jpma.23212

Vancouver

Rasheed MR, Farhat K, Ali S, Khan I, Malik RA. Comparison of the effectiveness of pirfenidone with corticosteroids in post-COVID fibrosis – A quasi experimental study. Journal of the Pakistan Medical Association. 2026;76(11):1824-1827. doi:10.47391/jpma.23212

BibTeX
@article{Rasheed2026,
  author = {Rasheed, Muhammad Rafay and Farhat, Kulsoom and Ali, Shabana and Khan, Ikramullah and Malik, Rizwan Abdul},
  title = {Comparison of the effectiveness of pirfenidone with corticosteroids in post-COVID fibrosis – A quasi experimental study},
  journal = {Journal of the Pakistan Medical Association},
  year = {2026},
  volume = {76},
  number = {11},
  pages = {1824--1827},
  doi = {10.47391/jpma.23212}
}
Kostenlos starten →